Elomotecan hydrochloride (BN 80927) is a potent inhibitor of topoisomerase I and II, exhibiting superior efficacy in reducing the proliferation of various tumor cells compared to reference anticancer agents targeting topoisomerase I and II; it is a camptothecin analog belonging to the homocamptothecin (hCPT) family.